Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-01-20

Clinical Trial Update: Curcumin for Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on curcumin for type 2 diabetes patients with cardiovascular abnormalities; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Srinakharinwirot University | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Abnormalities | Phase 4 | Status: UNKNOWN